C. Breton et al., BCL-2 EXPRESSION CORRELATES WITH APOPTOSIS INDUCTION BUT NOT LOSS OF CLONOGENIC SURVIVAL IN SMALL-CELL LUNG-CANCER CELL-LINES TREATED WITH ETOPOSIDE, Anti-cancer drugs, 9(9), 1998, pp. 751-757
The influence of bcl-2 oncogene expression on etoposide-induced apopto
sis and clonogenic survival was investigated in five small cell lung c
ancer (SCLC) cell lines, three of which were bcl-2-expressing and two
of which were non-bcl-2-expressing, The bcl-2-expressing lines display
ed a lower apoptosis propensity than the non-bcl-2-expressing lines. W
hen bcl-2-expressing cells were incubated in cystine/methionine-free (
CMF) medium, etoposide-induced apoptosis was restored to levels compar
able to those seen in non-bcl-2-expressing lines. However, the endpoin
t of clonogenic survival after drug treatment did not display any cons
istent pattern that correlated with bcl-2 status, In addition, treatme
nt of the two bcl-2-expressing cell lines with etoposide in CMF medium
did not modify their clonogenic survival curves compared to treatment
in regular medium. These results are consistent with the idea that bc
l-2 expression modulates etoposide-induced apoptosis but not clonogeni
c survival. [(C) 1998 Lippincott Williams & Wilkins.].